Dashboard
Manage Tickers

FULC


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

fulcrum-therapeutics-to-present-preclinical-data-on-ftx-6274-for-advanced-prostate-cancer-at-esmo-2025
Fulcrum Therapeutics to Present Preclinica...
10/14/2025 11:11:27

Fulcrum Therapeutics, Inc.® (Fulcrum) (NASDAQ:FULC), a clinical-stage biopharmaceutical company focused on developing small mol...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/25/2025 21:06:11

Gainers Galecto (NASDAQ: GLTO) stock rose 21.6% to $5.41 during Thursday's after-market session. The market value of their...

rbc-capital-maintains-sector-perform-on-fulcrum-therapeutics-raises-price-target-to-5
RBC Capital Maintains Sector Perform on Fu...
07/30/2025 14:26:59

RBC Capital analyst Luca Issi maintains Fulcrum Therapeutics (NASDAQ:FULC) with a Sector Perform and raises the price target...

avis-budget-group-posts-downbeat-earnings-joins-sofi-technologies-seagate-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
Avis Budget Group Posts Downbeat Earnings,...
07/30/2025 12:05:06

hc-wainwright--co-upgrades-fulcrum-therapeutics-to-buy-raises-price-target-to-12
HC Wainwright & Co. Upgrades Fulcrum Thera...
07/29/2025 15:34:05

HC Wainwright & Co. analyst Andrew Fein upgrades Fulcrum Therapeutics (NASDAQ:FULC) from Neutral to Buy and raises the p...

whirlpool-posts-downbeat-earnings-joins-harmonic-stanley-black--decker-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session
Whirlpool Posts Downbeat Earnings, Joins H...
07/29/2025 12:20:41

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
07/29/2025 12:07:53

fulcrum-therapeutics-q2-2025-eps-028-beats-029-estimate-ended-q2-with-2141m-in-cash-cash-equivalents-and-marketable-securities-cash-runway-into-2028
Fulcrum Therapeutics Q2 2025 EPS $(0.28) B...
07/29/2025 10:51:02

fulcrum-therapeutics-reports-results-from-12-mg-dose-cohort-of-phase-1b-pioneer-trial-of-pociredir-in-sickle-cell-disease
Fulcrum Therapeutics Reports Results From ...
07/29/2025 10:47:53

― Robust and clinically meaningful absolute mean fetal hemoglobin (HbF) induction of 8.6% from baseline at 12 weeks of treatmen...

why-celestica-shares-are-trading-higher-by-around-12-here-are-20-stocks-moving-premarket
Why Celestica Shares Are Trading Higher By...
07/29/2025 10:46:00

fulcrum-therapeutics-to-present-topline-results-from-12-mg-dose-cohort-of-phase-1b-pioneer-trial-of-pociredir-in-sickle-cell-disease
Fulcrum Therapeutics To Present Topline Re...
07/28/2025 20:02:21

Fulcrum Therapeutics, Inc.® (Fulcrum) (NASDAQ:FULC), a clinical-stage biopharmaceutical company focused on developing small mol...

piper-sandler-maintains-overweight-on-fulcrum-therapeutics-raises-price-target-to-9
Piper Sandler Maintains Overweight on Fulc...
05/29/2025 16:54:46

Piper Sandler analyst Edward Tenthoff maintains Fulcrum Therapeutics (NASDAQ:FULC) with a Overweight and raises the price ta...

leerink-partners-upgrades-fulcrum-therapeutics-to-outperform-raises-price-target-to-12
Leerink Partners Upgrades Fulcrum Therapeu...
05/23/2025 12:21:17

Leerink Partners analyst Joseph Schwartz upgrades Fulcrum Therapeutics (NASDAQ:FULC) from Market Perform to Outperform and r...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
05/23/2025 12:08:30

cantor-fitzgerald-upgrades-fulcrum-therapeutics-to-overweight-announces-10-price-target
Cantor Fitzgerald Upgrades Fulcrum Therape...
05/15/2025 15:28:21

Cantor Fitzgerald analyst Kristen Kluska upgrades Fulcrum Therapeutics (NASDAQ:FULC) from Neutral to Overweight and announce...

fulcrum-therapeutics-expects-current-cash-runway-be-sufficient-to-fund-operating-requirements-into-at-least-2027
Fulcrum Therapeutics Expects Current Cash ...
05/01/2025 11:08:15

Cash Runway GuidanceBased on its current operating plans, Fulcrum continues to expect that its current cash, cash equivalents, ...

fulcrum-therapeutics-q1-eps-028-beats-030-estimate-cash-and-equivalents-2266m
Fulcrum Therapeutics Q1 EPS $(0.28) Beats ...
05/01/2025 11:06:49

Fulcrum Therapeutics (NASDAQ:FULC) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of ...

Core News & Articles
Earnings Scheduled For May 1, 2025
05/01/2025 08:32:37

uncovering-potential-fulcrum-therapeuticss-earnings-preview
Uncovering Potential: Fulcrum Therapeutics...
04/30/2025 20:03:55

bristol-myers-acquired-myokardia-drops-fulcrum-agreement-ending-cardiomyopathy-research-deal
Bristol Myers Acquired MyoKardia Drops Ful...
03/05/2025 18:21:59

MyoKardia, a Bristol Myers unit, is terminating its agreement with Fulcrum Therapeutics, ending a cardiomyopathy research deal ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION